Plains GP Holdings (PAGP) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
23 Nov, 2025Executive summary
Q2 2025 Adjusted EBITDA was $672 million, with strong crude oil segment performance and strategic progress on the NGL business sale for $3.75 billion USD, expected to close in Q1 2026, enhancing cash flow durability and reducing commodity exposure.
Net income for the six months ended June 30, 2025 was $775 million, up 19% year-over-year, driven by higher contributions from continuing and discontinued operations.
Multiple bolt-on acquisitions were completed, including an additional 20% interest in BridgeTex Pipeline, increasing the JV stake to 40% and expanding the Permian Basin asset base.
Financial highlights
Q2 2025 crude oil segment Adjusted EBITDA was $580 million, benefiting from higher volumes, acquisitions, and refiner customer recovery.
NGL segment Adjusted EBITDA was $87 million for Q2 2025, down sequentially and year-over-year due to seasonality and lower spreads.
Full-year 2025 Adjusted EBITDA guidance is $2.8–$2.95 billion, with expectations to land in the lower half of the range.
Net income attributable to shareholders for the six months was $114 million, up 41% year-over-year; basic EPS was $0.58.
Distribution per common unit increased 20% year-over-year to $0.38 for Q2 2025.
Outlook and guidance
NGL business sale is expected to close in Q1 2026, with proceeds to be used for debt reduction, M&A, and unit repurchases.
2025 Adjusted EBITDA guidance remains $2.8–$2.95 billion; distributable cash flow forecasted at $1.875 billion, with a 175% coverage ratio.
Growth capital guidance for 2025 increased to $475 million, with maintenance capital trending at $230–$250 million.
Permian growth outlook for 2025 is 200,000–300,000 barrels per day, likely in the lower half of the range.
Latest events from Plains GP Holdings
- Exceeded guidance, raised distributions, and forecasted growth driven by acquisitions and Permian strength.PAGP
Q4 20249 Feb 2026 - Q2 2024 Adjusted EBITDA beat expectations; full-year guidance raised on strong execution.PAGP
Q2 20249 Feb 2026 - 2025 EBITDA reached $2.83B; 2026 targets $2.75B, with higher distributions and cost savings.PAGP
Q4 20256 Feb 2026 - Q3 Adjusted EBITDA $659M, leverage 3.0x, and Moody's upgrade support strong 2024 outlook.PAGP
Q3 202415 Jan 2026 - Strong 2024 results, disciplined capital returns, and robust governance drive value creation.PAGP
Proxy Filing2 Dec 2025 - Director elections, auditor ratification, and executive pay are up for vote at the 2025 meeting.PAGP
Proxy Filing2 Dec 2025 - Q1 2025 net income up 67%, Adjusted EBITDA $754M, strong growth and strategic acquisitions.PAGP
Q1 202526 Nov 2025 - Q3 2025 EBITDA hit $669M; net income doubled, with acquisitions and NGL sale refocusing strategy.PAGP
Q3 202513 Nov 2025 - Raised 2024 EBITDA guidance and delivered strong free cash flow with efficient growth.PAGP
Investor Reception Presentation25 Jun 2025